These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 9219761)

  • 21. Quantitative assessment of lesion load and efficacy of 3 cycles of albendazole in disseminated cysticercosis: a prospective evaluation.
    Pandey S; Malhotra HS; Garg RK; Malhotra KP; Kumar N; Rizvi I; Jain A; Kohli N; Verma R; Sharma P; Uniyal R; Pandey S
    BMC Infect Dis; 2020 Mar; 20(1):220. PubMed ID: 32171260
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical evaluation of albendazole and praziquantel in the treatment of cerebral cysticercosis.
    Cruz M; Cruz I; Horton J
    Southeast Asian J Trop Med Public Health; 1991 Dec; 22 Suppl():279-83. PubMed ID: 1822906
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Cysticerci-meningitis].
    Rogel-Ortiz F; Vera-Pedro M
    Gac Med Mex; 1997; 133(4):301-5. PubMed ID: 9410791
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Neurocysticercosis. Short course of treatment with albendazole.
    Alarcón F; Escalante L; Dueñas G; Montalvo M; Román M
    Arch Neurol; 1989 Nov; 46(11):1231-6. PubMed ID: 2818259
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Albendazole therapy for neurocysticercosis.
    Sanchetee PC; Venkataraman S; Dhamija RM; Roy AK
    J Assoc Physicians India; 1994 Feb; 42(2):116-7. PubMed ID: 7860469
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical spectrum of 500 children with neurocysticercosis and response to albendazole therapy.
    Singhi P; Ray M; Singhi S; Khandelwal N
    J Child Neurol; 2000 Apr; 15(4):207-13. PubMed ID: 10805184
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Treatment of porcine cysticercosis with albendazole.
    Gonzalez AE; Garcia HH; Gilman RH; Lopez MT; Gavidia C; McDonald J; Pilcher JB; Tsang VC
    Am J Trop Med Hyg; 1995 Nov; 53(5):571-4. PubMed ID: 7485720
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Neurocysticercosis: optimal dose treatment with albendazole.
    Cruz I; Cruz ME; Carrasco F; Horton J
    J Neurol Sci; 1995 Nov; 133(1-2):152-4. PubMed ID: 8583218
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Albendazole therapy for persistent, solitary cysticercus granulomas in patients with seizures.
    Rajshekhar V
    Neurology; 1993 Jun; 43(6):1238-40. PubMed ID: 8170573
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Intramedullary spinal cysticercosis: response to albendazole: case reports and review of literature.
    Garg RK; Nag D
    Spinal Cord; 1998 Jan; 36(1):67-70. PubMed ID: 9471142
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Albendazole and praziquantel treatment in neurocysticercosis of the fourth ventricle.
    Proaño JV; Madrazo I; García L; García-Torres E; Correa D
    J Neurosurg; 1997 Jul; 87(1):29-33. PubMed ID: 9202261
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Taenia crassiceps: host treatment alters glycolisis and tricarboxilic acid cycle in cysticerci.
    Fraga CM; Costa TL; Bezerra JC; de Souza Lino R; Vinaud MC
    Exp Parasitol; 2012 Feb; 130(2):146-51. PubMed ID: 22127328
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Selective sensitivity of cysts to praziquantel and albendazole in a case of cerebral cysticercosis].
    Cohen L; Belec L; Sanson M; Pierrot-Deseilligny C; Signoret JL
    Rev Neurol (Paris); 1992; 148(1):58-61. PubMed ID: 1604116
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Therapy for neurocysticercosis.
    Takayanagui OM
    Expert Rev Neurother; 2004 Jan; 4(1):129-39. PubMed ID: 15853623
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacokinetic optimisation of the treatment of neurocysticercosis.
    Sotelo J; Jung H
    Clin Pharmacokinet; 1998 Jun; 34(6):503-15. PubMed ID: 9646011
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Serologic evolution of neurocysticercosis patients after antiparasitic therapy. Cysticercosis Working Group in Peru.
    Garcia HH; Gilman RH; Catacora M; Verastegui M; Gonzalez AE; Tsang VC
    J Infect Dis; 1997 Feb; 175(2):486-9. PubMed ID: 9203680
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Oral albendazole in the management of extraocular cysticercosis.
    Sihota R; Honavar SG
    Br J Ophthalmol; 1994 Aug; 78(8):621-3. PubMed ID: 7918290
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Orbital cysticercosis.
    Gadkari SS; Bhabha SK; Jehangir RP; Adrianwala SD; Kirtane MV; Shah NA
    J Postgrad Med; 1992; 38(4):200-1, 198. PubMed ID: 1307595
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Subcutaneous cysticercosis involving the eyelid: sonographic diagnosis.
    Gupta S; Jain VK; Sen J; Gupta S; Arora B
    J Dermatol; 2000 Jan; 27(1):35-9. PubMed ID: 10692823
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Is the course of neurocysticercosis modified by treatment with antihelminthic agents?
    Carpio A; Santillán F; León P; Flores C; Hauser WA
    Arch Intern Med; 1995 Oct; 155(18):1982-8. PubMed ID: 7575052
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.